Laurion Capital Management LP 9 Meters Biopharma, Inc. Transaction History

Laurion Capital Management LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	BUY	$0.21 - $0.32 $1,074 - $1,637	5,116 Added 0.11%	4,558,200 $980,000
Q2 2022 Aug 15, 2022	BUY	$0.26 - $0.64 $1.18 Million - $2.91 Million	4,553,084 New	4,553,084 $1.19 Million

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.